DK3215143T3 - Kombination omfattende spirulina og palmitoylethanolamid - Google Patents
Kombination omfattende spirulina og palmitoylethanolamid Download PDFInfo
- Publication number
- DK3215143T3 DK3215143T3 DK15797430.4T DK15797430T DK3215143T3 DK 3215143 T3 DK3215143 T3 DK 3215143T3 DK 15797430 T DK15797430 T DK 15797430T DK 3215143 T3 DK3215143 T3 DK 3215143T3
- Authority
- DK
- Denmark
- Prior art keywords
- palmitoylethanolamide
- combination including
- including spirulina
- spirulina
- combination
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/748—Cyanobacteria, i.e. blue-green bacteria or blue-green algae, e.g. spirulina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITMI20141825 | 2014-10-22 | ||
PCT/IB2015/058074 WO2016063217A1 (en) | 2014-10-22 | 2015-10-20 | Combination comprising spirulina and palmitoylethanolamide and/or salts or pharmaceutically acceptable derivatives thereof and their formulations, for use in the prevention and/or in the treatment of hyperactivated tissue conditions |
Publications (1)
Publication Number | Publication Date |
---|---|
DK3215143T3 true DK3215143T3 (da) | 2021-09-20 |
Family
ID=51951920
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK15797430.4T DK3215143T3 (da) | 2014-10-22 | 2015-10-20 | Kombination omfattende spirulina og palmitoylethanolamid |
Country Status (12)
Country | Link |
---|---|
US (2) | US10646523B2 (da) |
EP (1) | EP3215143B1 (da) |
CA (1) | CA2964858C (da) |
DK (1) | DK3215143T3 (da) |
EA (1) | EA038593B1 (da) |
ES (1) | ES2886081T3 (da) |
HK (1) | HK1243327A1 (da) |
LT (1) | LT3215143T (da) |
MA (1) | MA40847A (da) |
PL (1) | PL3215143T3 (da) |
PT (1) | PT3215143T (da) |
WO (1) | WO2016063217A1 (da) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SG10201807034XA (en) | 2017-09-05 | 2019-04-29 | Frimline Private Ltd | A pharmaceutical composition for improving or preventing progression of Chronic Kidney Disease |
IT202000013156A1 (it) * | 2020-06-03 | 2021-12-03 | Welifepharma Sagl | Composizione oftalmica liquida comprendente un estratto acquoso di spirulina platensis. |
EP3991726A1 (en) * | 2020-11-02 | 2022-05-04 | Kura Srl | Anti-inflammatory composition comprising palmitoylethanolamide and phycocyanin |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE386056T1 (de) * | 2000-07-05 | 2008-03-15 | Bergter Wolfgang Dr | Zusammensetzung für pharmaka und kosmetika |
US20020120242A1 (en) * | 2000-12-22 | 2002-08-29 | Tyrrell David John | Absorbent articles with hydrophilic compositions containing botanicals |
WO2004045307A2 (en) * | 2002-11-18 | 2004-06-03 | Natural Asa | Dietry supplements and foods product comprising oleylethanolamide |
US20040258740A1 (en) * | 2003-04-10 | 2004-12-23 | Nene Labs | Transdermal delivery composition |
MA29706B1 (fr) * | 2007-02-14 | 2008-09-01 | Philippe Alleon | Complement alimentaire comprenant de la spiruline et un produit a base de plante du genre aloe, et son utilisation cosmetique |
US20080199489A1 (en) * | 2007-02-16 | 2008-08-21 | Parrinello Vincene M | Skin treatment formulations and method |
JP4803091B2 (ja) | 2007-03-30 | 2011-10-26 | コニカミノルタビジネステクノロジーズ株式会社 | 画像形成装置 |
TW200841883A (en) * | 2007-04-20 | 2008-11-01 | Microbio Company Ltd Taiwan | Composition for prevention and/or treatment of cancer |
WO2009088433A1 (en) * | 2008-01-04 | 2009-07-16 | Nestec S.A. | Compositions comprising unsaturated fatty acids and nitric oxide releasing compounds and use thereof for enhancing congnitive and related functions |
EP2444078B1 (en) * | 2010-10-04 | 2017-09-13 | EPITECH GROUP S.p.A. | Use of amides of mono and dicarboxylic acids in the treatment of renal diseases |
US20120107300A1 (en) * | 2010-11-01 | 2012-05-03 | Jeffrey Nathan Schirripa | Cannabinoid Compositions and Methods |
KR101408568B1 (ko) * | 2012-06-05 | 2014-06-17 | (주)하이모 | 황국균 및 유산균 복합발효기술을 이용한 발효효소식품의 제조 방법 |
NL2011448C2 (en) | 2012-09-17 | 2015-01-29 | Jp Russell Science Holding Ltd | Pharmaceutical or neutraceutical composition comprising palmitoylethanolamide particles. |
CN103156108B (zh) * | 2013-04-02 | 2015-03-18 | 曾晓飞 | 一种防治糖尿病高血压病症的强化食品 |
-
2015
- 2015-10-20 WO PCT/IB2015/058074 patent/WO2016063217A1/en active Application Filing
- 2015-10-20 ES ES15797430T patent/ES2886081T3/es active Active
- 2015-10-20 PT PT157974304T patent/PT3215143T/pt unknown
- 2015-10-20 US US15/519,611 patent/US10646523B2/en active Active
- 2015-10-20 CA CA2964858A patent/CA2964858C/en active Active
- 2015-10-20 EP EP15797430.4A patent/EP3215143B1/en active Active
- 2015-10-20 DK DK15797430.4T patent/DK3215143T3/da active
- 2015-10-20 PL PL15797430T patent/PL3215143T3/pl unknown
- 2015-10-20 EA EA201790899A patent/EA038593B1/ru unknown
- 2015-10-20 MA MA040847A patent/MA40847A/fr unknown
- 2015-10-20 LT LTEPPCT/IB2015/058074T patent/LT3215143T/lt unknown
-
2018
- 2018-02-27 HK HK18102792.6A patent/HK1243327A1/zh unknown
-
2020
- 2020-04-01 US US16/837,333 patent/US11311581B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
US11311581B2 (en) | 2022-04-26 |
US20170246227A1 (en) | 2017-08-31 |
EA201790899A1 (ru) | 2017-09-29 |
EP3215143B1 (en) | 2021-07-21 |
PT3215143T (pt) | 2021-08-31 |
EA038593B1 (ru) | 2021-09-21 |
MA40847A (fr) | 2017-09-13 |
PL3215143T3 (pl) | 2021-11-08 |
LT3215143T (lt) | 2021-10-25 |
WO2016063217A1 (en) | 2016-04-28 |
CA2964858A1 (en) | 2016-04-28 |
HK1243327A1 (zh) | 2018-07-13 |
EP3215143A1 (en) | 2017-09-13 |
CA2964858C (en) | 2023-10-24 |
US10646523B2 (en) | 2020-05-12 |
ES2886081T3 (es) | 2021-12-16 |
US20200222476A1 (en) | 2020-07-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FIC20230014I1 (fi) | Foslevodopa ja foskarbidopa | |
DK3235830T3 (da) | Interleukin-15-proteinkompleks og anvendelse deraf | |
DK3215147T3 (da) | Neurodæmpende norketamin-forbindelser og fremgangsmåder | |
DK3210977T3 (da) | Hidtil ukendt aminoalkylbenzothiazepinderivat og anvendelse deraf | |
DK3218358T3 (da) | Ifluorometyl-aminopyridiner og difluorometyl-aminopyrimidiner | |
DK3354282T3 (da) | Glycan-terapeutiske midler og relaterede fremgangsmåder deraf | |
DK3237418T3 (da) | Triazolopyrimidinforbindelser og anvendelser deraf | |
DK3333191T3 (da) | Anti-C10ORF54-antistoffer og anvendelser deraf | |
DK3212255T3 (da) | Selvorienterende sprøjte og sprøjtegrænseflade | |
DK3521289T3 (da) | Mnk-inhibitorer og fremgangsmåder forbundet dermed | |
DK3172213T3 (da) | Makrocykliske kinasehæmmere og anvendelser deraf | |
DK3155024T3 (da) | Opholdsstrukturer og relaterede fremgangsmåder | |
DK3169704T3 (da) | Molekyler med specificitet for cd45 og cd79 | |
DK3126388T3 (da) | Anti-EGFRvIII-antistoffer og anvendelser deraf | |
DK3015526T3 (da) | Hydrofluorolefinbaseret sammensætning og anvendelse deraf | |
DK3102200T3 (da) | Terapeutisk forbindelse og sammensætning | |
DK3101760T3 (da) | Opladningsfremgangsmåde og system | |
DK3103715T3 (da) | Styreindretning og styringsfremgangsmåde dertil | |
DK3220750T3 (da) | Oral rehydreringssammensætning og fremgangsmåder dertil | |
DK3161139T3 (da) | Tlr-4-specifikke aptamerer og anvendelser heraf | |
DK3265641T3 (da) | Stigørenhed og fremgangsmåde | |
DK3209773T3 (da) | Prolintolerante tripeptidylpeptidaser og anvendelser deraf | |
DK3128005T3 (da) | Sirp-alfa-variantkonstruktioner og anvendelser deraf | |
DK3233105T3 (da) | Hidtil ukendt kombination og anvendelse | |
FI20146023A (fi) | Hammas- ja kielituki |